| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:51 UTC |
|---|
| Update Date | 2022-03-07 02:51:57 UTC |
|---|
| HMDB ID | HMDB0015339 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Sparfloxacin |
|---|
| Description | Sparfloxacin, also known as SPFX or zagam, belongs to the class of organic compounds known as quinoline carboxylic acids. These are quinolines in which the quinoline ring system is substituted by a carboxyl group at one or more positions. Sparfloxacin is a drug which is used for the treatment of adults with the following infections caused by susceptible strains microorganisms: community-acquired pneumonia (caused by chlamydia pneumoniae, haemophilus influenzae, haemophilus parainfluenzae, moraxella catarrhalis, mycoplasma pneumoniae, or streptococcus pneumoniae) and acute bacterial exacerbations of chronic bronchitis (caused by chlamydia pneumoniae, enterobacter cloacae, haemophilus influenzae, haemophilus parainfluenzae, klebsiella pneumoniae, moraxella catarrhalis, staphylococcus aureus, or streptococcus pneumoniae). Sparfloxacin is a very strong basic compound (based on its pKa). Following a single 400 mg oral dose of sparfloxacin, the mean peak concentration in cantharides-induced inflammatory fluid is 1.3 lA-g per ml after a mean duration of 5 h post-dose. The incidence of phototoxicity associated with sparfloxacin appears to be higher than that observed with ciprofloxacin and ofloxacin but less than that reported for fleroxacin, pefloxacin, enoxacin and nalidixic acid. For many gram-negative bacteria DNA gyrase is the target, whereas topoisomerase IV is the target for many gram-positive bacteria. The overall rates of drug-related adverse reactions for sparfloxacin 400/200 mg versus comparators and 200/100 mg versus the comparator (amoxicillin/clavulanic acid) were 13.7 versus 17.7%, and 9.5 versus 13.2%, respectively. |
|---|
| Structure | C[C@H]1CN(C[C@@H](C)N1)C1=C(F)C(N)=C2C(=O)C(=CN(C3CC3)C2=C1F)C(O)=O InChI=1S/C19H22F2N4O3/c1-8-5-24(6-9(2)23-8)17-13(20)15(22)12-16(14(17)21)25(10-3-4-10)7-11(18(12)26)19(27)28/h7-10,23H,3-6,22H2,1-2H3,(H,27,28)/t8-,9+ |
|---|
| Synonyms | | Value | Source |
|---|
| cis-5-Amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid | ChEBI | | SPFX | Kegg | | Zagam | Kegg | | cis-5-Amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylate | Generator | | 5-Amino-1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)- 6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid | HMDB |
|
|---|
| Chemical Formula | C19H22F2N4O3 |
|---|
| Average Molecular Weight | 392.3998 |
|---|
| Monoisotopic Molecular Weight | 392.165997 |
|---|
| IUPAC Name | 5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
|---|
| Traditional Name | sparfloxacin |
|---|
| CAS Registry Number | 110871-86-8 |
|---|
| SMILES | C[C@H]1CN(C[C@@H](C)N1)C1=C(F)C(N)=C2C(=O)C(=CN(C3CC3)C2=C1F)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C19H22F2N4O3/c1-8-5-24(6-9(2)23-8)17-13(20)15(22)12-16(14(17)21)25(10-3-4-10)7-11(18(12)26)19(27)28/h7-10,23H,3-6,22H2,1-2H3,(H,27,28)/t8-,9+ |
|---|
| InChI Key | DZZWHBIBMUVIIW-DTORHVGOSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as quinoline carboxylic acids. These are quinolines in which the quinoline ring system is substituted by a carboxyl group at one or more positions. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Quinolines and derivatives |
|---|
| Sub Class | Quinoline carboxylic acids |
|---|
| Direct Parent | Quinoline carboxylic acids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Quinoline-3-carboxylic acid
- Fluoroquinolone
- N-arylpiperazine
- Aminoquinoline
- Haloquinoline
- Dihydroquinolone
- Dihydroquinoline
- Pyridine carboxylic acid
- Pyridine carboxylic acid or derivatives
- Dialkylarylamine
- Tertiary aliphatic/aromatic amine
- Benzenoid
- Aryl fluoride
- Pyridine
- Aryl halide
- 1,4-diazinane
- Piperazine
- Vinylogous amide
- Heteroaromatic compound
- Tertiary amine
- Amino acid
- Amino acid or derivatives
- Azacycle
- Secondary amine
- Carboxylic acid derivative
- Carboxylic acid
- Secondary aliphatic amine
- Monocarboxylic acid or derivatives
- Organopnictogen compound
- Organic oxygen compound
- Primary amine
- Hydrocarbon derivative
- Organic nitrogen compound
- Organic oxide
- Amine
- Organohalogen compound
- Organofluoride
- Organonitrogen compound
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.11 g/L | Not Available | | LogP | 2.5 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.92 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.6895 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 4.37 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 220.9 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 538.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 177.6 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 92.8 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 157.7 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 56.7 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 285.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 309.0 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 548.4 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 640.2 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 50.0 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 561.5 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 165.6 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 237.1 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 528.9 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 583.8 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 96.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Sparfloxacin,1TMS,isomer #1 | C[C@H]1CN(C2=C(F)C(N)=C3C(=O)C(C(=O)O[Si](C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1 | 3461.0 | Semi standard non polar | 33892256 | | Sparfloxacin,1TMS,isomer #2 | C[C@H]1CN(C2=C(F)C(N[Si](C)(C)C)=C3C(=O)C(C(=O)O)=CN(C4CC4)C3=C2F)C[C@@H](C)N1 | 3569.3 | Semi standard non polar | 33892256 | | Sparfloxacin,1TMS,isomer #3 | C[C@H]1CN(C2=C(F)C(N)=C3C(=O)C(C(=O)O)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C | 3421.0 | Semi standard non polar | 33892256 | | Sparfloxacin,2TMS,isomer #1 | C[C@H]1CN(C2=C(F)C(N[Si](C)(C)C)=C3C(=O)C(C(=O)O[Si](C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1 | 3463.6 | Semi standard non polar | 33892256 | | Sparfloxacin,2TMS,isomer #1 | C[C@H]1CN(C2=C(F)C(N[Si](C)(C)C)=C3C(=O)C(C(=O)O[Si](C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1 | 2967.7 | Standard non polar | 33892256 | | Sparfloxacin,2TMS,isomer #1 | C[C@H]1CN(C2=C(F)C(N[Si](C)(C)C)=C3C(=O)C(C(=O)O[Si](C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1 | 3833.3 | Standard polar | 33892256 | | Sparfloxacin,2TMS,isomer #2 | C[C@H]1CN(C2=C(F)C(N)=C3C(=O)C(C(=O)O[Si](C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C | 3343.2 | Semi standard non polar | 33892256 | | Sparfloxacin,2TMS,isomer #2 | C[C@H]1CN(C2=C(F)C(N)=C3C(=O)C(C(=O)O[Si](C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C | 3077.3 | Standard non polar | 33892256 | | Sparfloxacin,2TMS,isomer #2 | C[C@H]1CN(C2=C(F)C(N)=C3C(=O)C(C(=O)O[Si](C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C | 4137.4 | Standard polar | 33892256 | | Sparfloxacin,2TMS,isomer #3 | C[C@H]1CN(C2=C(F)C(N([Si](C)(C)C)[Si](C)(C)C)=C3C(=O)C(C(=O)O)=CN(C4CC4)C3=C2F)C[C@@H](C)N1 | 3424.7 | Semi standard non polar | 33892256 | | Sparfloxacin,2TMS,isomer #3 | C[C@H]1CN(C2=C(F)C(N([Si](C)(C)C)[Si](C)(C)C)=C3C(=O)C(C(=O)O)=CN(C4CC4)C3=C2F)C[C@@H](C)N1 | 3114.5 | Standard non polar | 33892256 | | Sparfloxacin,2TMS,isomer #3 | C[C@H]1CN(C2=C(F)C(N([Si](C)(C)C)[Si](C)(C)C)=C3C(=O)C(C(=O)O)=CN(C4CC4)C3=C2F)C[C@@H](C)N1 | 3829.6 | Standard polar | 33892256 | | Sparfloxacin,2TMS,isomer #4 | C[C@H]1CN(C2=C(F)C(N[Si](C)(C)C)=C3C(=O)C(C(=O)O)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C | 3461.0 | Semi standard non polar | 33892256 | | Sparfloxacin,2TMS,isomer #4 | C[C@H]1CN(C2=C(F)C(N[Si](C)(C)C)=C3C(=O)C(C(=O)O)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C | 3045.4 | Standard non polar | 33892256 | | Sparfloxacin,2TMS,isomer #4 | C[C@H]1CN(C2=C(F)C(N[Si](C)(C)C)=C3C(=O)C(C(=O)O)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C | 3874.6 | Standard polar | 33892256 | | Sparfloxacin,3TMS,isomer #1 | C[C@H]1CN(C2=C(F)C(N([Si](C)(C)C)[Si](C)(C)C)=C3C(=O)C(C(=O)O[Si](C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1 | 3325.1 | Semi standard non polar | 33892256 | | Sparfloxacin,3TMS,isomer #1 | C[C@H]1CN(C2=C(F)C(N([Si](C)(C)C)[Si](C)(C)C)=C3C(=O)C(C(=O)O[Si](C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1 | 3215.7 | Standard non polar | 33892256 | | Sparfloxacin,3TMS,isomer #1 | C[C@H]1CN(C2=C(F)C(N([Si](C)(C)C)[Si](C)(C)C)=C3C(=O)C(C(=O)O[Si](C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1 | 3561.4 | Standard polar | 33892256 | | Sparfloxacin,3TMS,isomer #2 | C[C@H]1CN(C2=C(F)C(N[Si](C)(C)C)=C3C(=O)C(C(=O)O[Si](C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C | 3382.4 | Semi standard non polar | 33892256 | | Sparfloxacin,3TMS,isomer #2 | C[C@H]1CN(C2=C(F)C(N[Si](C)(C)C)=C3C(=O)C(C(=O)O[Si](C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C | 3132.8 | Standard non polar | 33892256 | | Sparfloxacin,3TMS,isomer #2 | C[C@H]1CN(C2=C(F)C(N[Si](C)(C)C)=C3C(=O)C(C(=O)O[Si](C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C | 3657.6 | Standard polar | 33892256 | | Sparfloxacin,3TMS,isomer #3 | C[C@H]1CN(C2=C(F)C(N([Si](C)(C)C)[Si](C)(C)C)=C3C(=O)C(C(=O)O)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C | 3369.1 | Semi standard non polar | 33892256 | | Sparfloxacin,3TMS,isomer #3 | C[C@H]1CN(C2=C(F)C(N([Si](C)(C)C)[Si](C)(C)C)=C3C(=O)C(C(=O)O)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C | 3295.6 | Standard non polar | 33892256 | | Sparfloxacin,3TMS,isomer #3 | C[C@H]1CN(C2=C(F)C(N([Si](C)(C)C)[Si](C)(C)C)=C3C(=O)C(C(=O)O)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C | 3605.1 | Standard polar | 33892256 | | Sparfloxacin,4TMS,isomer #1 | C[C@H]1CN(C2=C(F)C(N([Si](C)(C)C)[Si](C)(C)C)=C3C(=O)C(C(=O)O[Si](C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C | 3347.7 | Semi standard non polar | 33892256 | | Sparfloxacin,4TMS,isomer #1 | C[C@H]1CN(C2=C(F)C(N([Si](C)(C)C)[Si](C)(C)C)=C3C(=O)C(C(=O)O[Si](C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C | 3374.8 | Standard non polar | 33892256 | | Sparfloxacin,4TMS,isomer #1 | C[C@H]1CN(C2=C(F)C(N([Si](C)(C)C)[Si](C)(C)C)=C3C(=O)C(C(=O)O[Si](C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C | 3425.6 | Standard polar | 33892256 | | Sparfloxacin,1TBDMS,isomer #1 | C[C@H]1CN(C2=C(F)C(N)=C3C(=O)C(C(=O)O[Si](C)(C)C(C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1 | 3657.7 | Semi standard non polar | 33892256 | | Sparfloxacin,1TBDMS,isomer #2 | C[C@H]1CN(C2=C(F)C(N[Si](C)(C)C(C)(C)C)=C3C(=O)C(C(=O)O)=CN(C4CC4)C3=C2F)C[C@@H](C)N1 | 3781.2 | Semi standard non polar | 33892256 | | Sparfloxacin,1TBDMS,isomer #3 | C[C@H]1CN(C2=C(F)C(N)=C3C(=O)C(C(=O)O)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C(C)(C)C | 3679.2 | Semi standard non polar | 33892256 | | Sparfloxacin,2TBDMS,isomer #1 | C[C@H]1CN(C2=C(F)C(N[Si](C)(C)C(C)(C)C)=C3C(=O)C(C(=O)O[Si](C)(C)C(C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1 | 3841.6 | Semi standard non polar | 33892256 | | Sparfloxacin,2TBDMS,isomer #1 | C[C@H]1CN(C2=C(F)C(N[Si](C)(C)C(C)(C)C)=C3C(=O)C(C(=O)O[Si](C)(C)C(C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1 | 3402.1 | Standard non polar | 33892256 | | Sparfloxacin,2TBDMS,isomer #1 | C[C@H]1CN(C2=C(F)C(N[Si](C)(C)C(C)(C)C)=C3C(=O)C(C(=O)O[Si](C)(C)C(C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1 | 3960.1 | Standard polar | 33892256 | | Sparfloxacin,2TBDMS,isomer #2 | C[C@H]1CN(C2=C(F)C(N)=C3C(=O)C(C(=O)O[Si](C)(C)C(C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C(C)(C)C | 3784.7 | Semi standard non polar | 33892256 | | Sparfloxacin,2TBDMS,isomer #2 | C[C@H]1CN(C2=C(F)C(N)=C3C(=O)C(C(=O)O[Si](C)(C)C(C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C(C)(C)C | 3467.8 | Standard non polar | 33892256 | | Sparfloxacin,2TBDMS,isomer #2 | C[C@H]1CN(C2=C(F)C(N)=C3C(=O)C(C(=O)O[Si](C)(C)C(C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C(C)(C)C | 4181.9 | Standard polar | 33892256 | | Sparfloxacin,2TBDMS,isomer #3 | C[C@H]1CN(C2=C(F)C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3C(=O)C(C(=O)O)=CN(C4CC4)C3=C2F)C[C@@H](C)N1 | 3864.4 | Semi standard non polar | 33892256 | | Sparfloxacin,2TBDMS,isomer #3 | C[C@H]1CN(C2=C(F)C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3C(=O)C(C(=O)O)=CN(C4CC4)C3=C2F)C[C@@H](C)N1 | 3563.3 | Standard non polar | 33892256 | | Sparfloxacin,2TBDMS,isomer #3 | C[C@H]1CN(C2=C(F)C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3C(=O)C(C(=O)O)=CN(C4CC4)C3=C2F)C[C@@H](C)N1 | 3913.8 | Standard polar | 33892256 | | Sparfloxacin,2TBDMS,isomer #4 | C[C@H]1CN(C2=C(F)C(N[Si](C)(C)C(C)(C)C)=C3C(=O)C(C(=O)O)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C(C)(C)C | 3921.7 | Semi standard non polar | 33892256 | | Sparfloxacin,2TBDMS,isomer #4 | C[C@H]1CN(C2=C(F)C(N[Si](C)(C)C(C)(C)C)=C3C(=O)C(C(=O)O)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C(C)(C)C | 3462.1 | Standard non polar | 33892256 | | Sparfloxacin,2TBDMS,isomer #4 | C[C@H]1CN(C2=C(F)C(N[Si](C)(C)C(C)(C)C)=C3C(=O)C(C(=O)O)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C(C)(C)C | 3951.5 | Standard polar | 33892256 | | Sparfloxacin,3TBDMS,isomer #1 | C[C@H]1CN(C2=C(F)C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3C(=O)C(C(=O)O[Si](C)(C)C(C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1 | 3879.0 | Semi standard non polar | 33892256 | | Sparfloxacin,3TBDMS,isomer #1 | C[C@H]1CN(C2=C(F)C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3C(=O)C(C(=O)O[Si](C)(C)C(C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1 | 3820.4 | Standard non polar | 33892256 | | Sparfloxacin,3TBDMS,isomer #1 | C[C@H]1CN(C2=C(F)C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3C(=O)C(C(=O)O[Si](C)(C)C(C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1 | 3768.6 | Standard polar | 33892256 | | Sparfloxacin,3TBDMS,isomer #2 | C[C@H]1CN(C2=C(F)C(N[Si](C)(C)C(C)(C)C)=C3C(=O)C(C(=O)O[Si](C)(C)C(C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C(C)(C)C | 3961.0 | Semi standard non polar | 33892256 | | Sparfloxacin,3TBDMS,isomer #2 | C[C@H]1CN(C2=C(F)C(N[Si](C)(C)C(C)(C)C)=C3C(=O)C(C(=O)O[Si](C)(C)C(C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C(C)(C)C | 3762.5 | Standard non polar | 33892256 | | Sparfloxacin,3TBDMS,isomer #2 | C[C@H]1CN(C2=C(F)C(N[Si](C)(C)C(C)(C)C)=C3C(=O)C(C(=O)O[Si](C)(C)C(C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C(C)(C)C | 3853.3 | Standard polar | 33892256 | | Sparfloxacin,3TBDMS,isomer #3 | C[C@H]1CN(C2=C(F)C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3C(=O)C(C(=O)O)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C(C)(C)C | 4047.8 | Semi standard non polar | 33892256 | | Sparfloxacin,3TBDMS,isomer #3 | C[C@H]1CN(C2=C(F)C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3C(=O)C(C(=O)O)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C(C)(C)C | 3889.1 | Standard non polar | 33892256 | | Sparfloxacin,3TBDMS,isomer #3 | C[C@H]1CN(C2=C(F)C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3C(=O)C(C(=O)O)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C(C)(C)C | 3772.3 | Standard polar | 33892256 | | Sparfloxacin,4TBDMS,isomer #1 | C[C@H]1CN(C2=C(F)C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3C(=O)C(C(=O)O[Si](C)(C)C(C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C(C)(C)C | 4079.9 | Semi standard non polar | 33892256 | | Sparfloxacin,4TBDMS,isomer #1 | C[C@H]1CN(C2=C(F)C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3C(=O)C(C(=O)O[Si](C)(C)C(C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C(C)(C)C | 4108.1 | Standard non polar | 33892256 | | Sparfloxacin,4TBDMS,isomer #1 | C[C@H]1CN(C2=C(F)C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3C(=O)C(C(=O)O[Si](C)(C)C(C)(C)C)=CN(C4CC4)C3=C2F)C[C@@H](C)N1[Si](C)(C)C(C)(C)C | 3703.7 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Sparfloxacin GC-MS (Non-derivatized) - 70eV, Positive | splash10-0fb9-1019000000-5b550920c5bbc4b2c955 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Sparfloxacin GC-MS (1 TMS) - 70eV, Positive | splash10-0002-1003900000-b02ecf08f1f9d753e51c | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Sparfloxacin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Sparfloxacin DI-ESI-qTof , Negative-QTOF | splash10-052b-0009000000-d679c676e007f977b21f | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sparfloxacin LC-ESI-qTof , Positive-QTOF | splash10-000j-0922000000-9b26b987caa87b8a13af | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sparfloxacin , positive-QTOF | splash10-0006-1269000000-99d4bb9a3315f1f23139 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sparfloxacin , positive-QTOF | splash10-000j-0922000000-9b26b987caa87b8a13af | 2017-09-14 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sparfloxacin 10V, Positive-QTOF | splash10-002f-0009000000-cb9b21c65927ebb5d2fc | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sparfloxacin 20V, Positive-QTOF | splash10-0006-5009000000-8bc0dbc8c167be4d9e89 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sparfloxacin 40V, Positive-QTOF | splash10-0006-9053000000-1f8fe8577ffbcaa296e8 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sparfloxacin 10V, Negative-QTOF | splash10-0005-0009000000-556e774c1186ed5914bd | 2016-08-04 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sparfloxacin 20V, Negative-QTOF | splash10-0032-0009000000-3464b524d8fe5818d653 | 2016-08-04 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sparfloxacin 40V, Negative-QTOF | splash10-0a4i-8049000000-c6ff684a5d90eb56916a | 2016-08-04 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sparfloxacin 10V, Positive-QTOF | splash10-0006-0009000000-74d4005d84956dd50275 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sparfloxacin 20V, Positive-QTOF | splash10-004i-0009000000-9fa0d7fb5222b16d5f08 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sparfloxacin 40V, Positive-QTOF | splash10-0006-1069000000-ef032ddc6b4cfeb5a5c7 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sparfloxacin 10V, Negative-QTOF | splash10-0006-0009000000-09bb26c2b66f78b9179b | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sparfloxacin 20V, Negative-QTOF | splash10-0006-0009000000-5bf5ba0c21f5b794211d | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sparfloxacin 40V, Negative-QTOF | splash10-0006-0079000000-e76ec9c04e79503d3c7e | 2021-10-11 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum |
|
|---|